metronidazole has been researched along with Sexually Transmitted Diseases in 71 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Sexually Transmitted Diseases: Diseases due to or propagated by sexual contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "10 cases of bacterial vaginosis were found and 35 pathogens (E." | 6.74 | Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study. ( Judlin, P; Thiebaugeorges, O, 2009) |
| " A histological finding on the 15th day indicated the possibility of amoebic enteritis, and the patient was started on metronidazole therapy." | 3.81 | Fulminant amoebic enteritis that developed in the perinatal period. ( Goto, M; Matsuoka, T; Mizushima, Y, 2015) |
| "In the United Kingdom many genitourinary medicine clinics use oral doxycycline and metronidazole to treat pelvic inflammatory disease (PID)." | 3.73 | Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy. ( Piyadigamage, A; Wilson, J, 2005) |
| "10 cases of bacterial vaginosis were found and 35 pathogens (E." | 2.74 | Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study. ( Judlin, P; Thiebaugeorges, O, 2009) |
| "Sexually transmitted diseases were reduced: Trichomonas vaginalis (rate ratio, 0." | 2.70 | Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. ( Abramowsky, C; Gray, RH; Kigozi, G; Meehan, M; Moulton, LH; O'Brien, KL; Quinn, TC; Robb, M; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ, 2001) |
| "Testing the effects of STD control on AIDS prevention is feasible in this Ugandan setting." | 2.69 | A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. ( Berkley, S; Brookmeyer, R; Gray, RH; Kelly, R; Kiwanuka, N; Li, C; Lutalo, T; McNairn, D; Nalugoda, F; Paxton, L; Quinn, TC; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ, 1998) |
| "Follow-up is required in women with sexually transmitted infections (STIs) (grade C)." | 2.66 | Pelvic inflammatory diseases: Updated French guidelines. ( Brun, JL; Castan, B; Cazanave, C; Charvériat, A; de Barbeyrac, B; Faure, K; Fritel, X; Graesslin, O; Mignot, S; Verdon, R, 2020) |
| "In addition, trichomoniasis increases patient susceptibility to HIV infection." | 2.49 | In vitro effects of various plants extracts on the growth of Trichomonas vaginalis. ( Asghari, G; Darani, HY; Sharafi, SM; Yousefi, HA; Yousefi, M, 2013) |
| "T." | 2.45 | Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica. ( Honek, JF; Moya, IA; Su, Z, 2009) |
| "Metronidazole treatment is generally efficient in eliminating T." | 2.42 | Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. ( Cudmore, SL; Delgaty, KL; Garber, GE; Hayward-McClelland, SF; Petrin, DP, 2004) |
| "Prevention and treatment of sexually transmitted infections (STIs) in the sexually active population are the main steps to prevent perinatal infection." | 2.41 | Sexually transmitted infections, adverse pregnancy outcome and neonatal infection. ( Moodley, P; Sturm, AW, 2000) |
| "Complications of bacterial vaginosis may be associated with significant morbidity, especially among pregnant women." | 2.39 | Treatment of bacterial vaginosis. ( Schlicht, JR, 1994) |
| "The recommended treatment for gonorrhea is ceftriaxone monotherapy given intramuscularly, with dosing based on the patient's body weight." | 1.72 | Sexually Transmitted Infections: Updates From the 2021 CDC Guidelines. ( Dalby, J; Stoner, BP, 2022) |
| "It is associated with other STIs, adverse pregnancy outcomes and pelvic inflammatory disease." | 1.51 | Survey of Obstetrician-gynecologists in the United States About Trichomoniasis, 2016. ( Jones, JL; Liu, EW; Schulkin, J; Secor, WE; Taouk, LH; Workowski, KA, 2019) |
| " Mounting recent evidence has shown that the 7-day oral metronidazole dosing regimen is more efficacious than the single 2-g dose." | 1.51 | Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women? ( Kissinger, P; Muzny, CA; Richter, S, 2019) |
| "Trichomoniasis is the most common non-viral, sexually transmitted infection affecting humans worldwide." | 1.48 | Chlorinated metronidazole as a promising alternative for treating trichomoniasis. ( Alacoque, MA; Alves, RJ; Campos-Mota, GP; Capettini, LSA; Cassali, GD; Chacon, MO; Fonseca, THS; Franco, LL; Gomes, MA; Oliveira, SBV; Tagliati, CA, 2018) |
| "Metronidazole (MTZ) is a 5-nitroimidazole drug used for the treatment of Trichomonas vaginalis parasitic infection." | 1.48 | Phase solubility studies and anti-Trichomonas vaginalis activity evaluations of metronidazole and methylated β-cyclodextrin complexes: Comparison of CRYSMEB and RAMEB. ( Bories, C; Bouchemal, K; Loiseau, PM; Malli, S; Ponchel, G, 2018) |
| "Vulvovaginal candidiasis affects 75% of women at least once." | 1.42 | Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. ( van Schalkwyk, J; Yudin, MH, 2015) |
| " Treatment regimens varied: 20% received single 2-g dosing of either metronidazole or tinidazole, 50% received high-dose regimens, 20% received therapy with vaginal paromomycin, and 10% underwent desensitization for nitroimidazole allergy." | 1.42 | Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center. ( Keating, MA; Nyirjesy, P, 2015) |
| "With more clinical trials involving evaluations of new drugs or vaccines, monitoring for early detection of adverse events is essential." | 1.33 | Design and implementation of Cell-PREVEN: a real-time surveillance system for adverse events using cell phones in Peru. ( Buendia, C; Campos, PE; Curioso, WH; Holmes, KK; Karras, BT; Kimball, AM, 2005) |
| "As part of a larger program to control STDs, incorporating metronidazole to treat male trichomoniasis could represent a cost-effective means to reduce HIV transmission in this high-risk group." | 1.33 | The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi. ( Behets, F; Chilongozi, D; Cohen, MS; Dow, WH; Martinson, FE; Miller, WC; Price, MA; Stewart, SR, 2006) |
| "Bacterial vaginosis was present in 32% of the women screened, Chlamydia trachomatis was identified in 8%, none tested positive for Neisseria gonorrhoeae." | 1.32 | Should we offer antibiotic prophylaxis post sexual assault? ( Forster, GE; Gibb, AM; McManus, T, 2003) |
| "Metronidazole was provided to 67 (69%) of 97 women with TV because of TV on wet preparation, exposure to TV, or a diagnosis of bacterial vaginosis or pelvic inflammatory disease; however, if TV PCR had been used for diagnosis, 81 (84%) of 97 women with TV would have been treated (P=." | 1.31 | Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. ( Erbelding, EJ; Gaydos, CA; Rompalo, AM; Wendel, KA, 2002) |
| "Research on the relationship between sexually transmitted diseases (STDs) and HIV was presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)." | 1.30 | Data on HIV infection in women expands. ( Eagan, L, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (29.58) | 18.7374 |
| 1990's | 8 (11.27) | 18.2507 |
| 2000's | 15 (21.13) | 29.6817 |
| 2010's | 21 (29.58) | 24.3611 |
| 2020's | 6 (8.45) | 2.80 |
| Authors | Studies |
|---|---|
| Mandalapu, D | 1 |
| Kushwaha, B | 1 |
| Gupta, S | 1 |
| Singh, N | 1 |
| Shukla, M | 1 |
| Kumar, J | 1 |
| Tanpula, DK | 1 |
| Sankhwar, SN | 1 |
| Maikhuri, JP | 1 |
| Siddiqi, MI | 1 |
| Lal, J | 1 |
| Gupta, G | 1 |
| Sharma, VL | 1 |
| Kissinger, PJ | 1 |
| Gaydos, CA | 3 |
| Seña, AC | 2 |
| Scott McClelland, R | 2 |
| Soper, D | 1 |
| Secor, WE | 4 |
| Legendre, D | 1 |
| Workowski, KA | 3 |
| Muzny, CA | 4 |
| Dalby, J | 1 |
| Stoner, BP | 1 |
| Van Gerwen, OT | 1 |
| Kissinger, P | 3 |
| Brun, JL | 1 |
| Castan, B | 1 |
| de Barbeyrac, B | 1 |
| Cazanave, C | 1 |
| Charvériat, A | 1 |
| Faure, K | 1 |
| Mignot, S | 1 |
| Verdon, R | 1 |
| Fritel, X | 1 |
| Graesslin, O | 1 |
| Sim, M | 1 |
| Logan, S | 1 |
| Goh, LH | 1 |
| Selim, MA | 1 |
| Fawzy, EM | 1 |
| Abd El-Rahman, EM | 1 |
| Abdel Hady, RS | 1 |
| Badr, MS | 1 |
| Abdel Hamed, EF | 1 |
| Chacon, MO | 1 |
| Fonseca, THS | 1 |
| Oliveira, SBV | 1 |
| Alacoque, MA | 1 |
| Franco, LL | 1 |
| Tagliati, CA | 1 |
| Cassali, GD | 1 |
| Campos-Mota, GP | 1 |
| Alves, RJ | 1 |
| Capettini, LSA | 1 |
| Gomes, MA | 1 |
| Malli, S | 1 |
| Bories, C | 1 |
| Ponchel, G | 1 |
| Loiseau, PM | 1 |
| Bouchemal, K | 1 |
| Liu, EW | 1 |
| Taouk, LH | 1 |
| Schulkin, J | 1 |
| Jones, JL | 1 |
| Kumar, S | 1 |
| Bains, T | 1 |
| Won Kim, AS | 1 |
| Tam, C | 1 |
| Kim, J | 1 |
| Cheng, LW | 1 |
| Land, KM | 1 |
| Debnath, A | 1 |
| Kumar, V | 1 |
| Küng, E | 1 |
| Fürnkranz, U | 1 |
| Walochnik, J | 1 |
| Richter, S | 1 |
| Woods, JL | 1 |
| Scurlock, AM | 1 |
| Hensel, DJ | 1 |
| Schwebke, JR | 3 |
| Lensing, SY | 1 |
| Sobel, J | 1 |
| McCormick, DF | 1 |
| Rahman, M | 1 |
| Zadrozny, S | 1 |
| Alam, A | 1 |
| Ashraf, L | 1 |
| Neilsen, GA | 1 |
| Kelly, R | 2 |
| Menezes, P | 1 |
| Miller, WC | 2 |
| Hoffman, IF | 1 |
| Bachmann, LH | 1 |
| Hobbs, MM | 1 |
| Sharafi, SM | 1 |
| Yousefi, M | 1 |
| Yousefi, HA | 1 |
| Asghari, G | 1 |
| Darani, HY | 1 |
| Blackburn, RJ | 1 |
| Sinsky, RJ | 1 |
| Austin, EL | 1 |
| van Schalkwyk, J | 1 |
| Yudin, MH | 1 |
| Goto, M | 1 |
| Mizushima, Y | 1 |
| Matsuoka, T | 1 |
| Keating, MA | 1 |
| Nyirjesy, P | 1 |
| Balkus, JE | 1 |
| Manhart, LE | 1 |
| Lee, J | 1 |
| Anzala, O | 1 |
| Kimani, J | 1 |
| Schwebke, J | 1 |
| Shafi, J | 1 |
| Rivers, C | 1 |
| Kabare, E | 1 |
| Judlin, P | 1 |
| Thiebaugeorges, O | 1 |
| Moya, IA | 1 |
| Su, Z | 1 |
| Honek, JF | 1 |
| Conrad, MD | 1 |
| Gorman, AW | 1 |
| Schillinger, JA | 1 |
| Fiori, PL | 1 |
| Arroyo, R | 1 |
| Malla, N | 1 |
| Dubey, ML | 1 |
| Gonzalez, J | 1 |
| Blank, S | 1 |
| Carlton, JM | 1 |
| Kirkcaldy, RD | 1 |
| Augostini, P | 1 |
| Asbel, LE | 1 |
| Bernstein, KT | 1 |
| Kerani, RP | 1 |
| Mettenbrink, CJ | 1 |
| Pathela, P | 1 |
| Davis, D | 1 |
| Braxton, J | 1 |
| Weinstock, HS | 1 |
| Coleman, JS | 1 |
| Witter, F | 1 |
| Wendel, KA | 1 |
| Erbelding, EJ | 1 |
| Rompalo, AM | 1 |
| Steben, M | 1 |
| Ressel, GW | 1 |
| Gibb, AM | 1 |
| McManus, T | 1 |
| Forster, GE | 1 |
| Dunne, RL | 1 |
| Dunn, LA | 1 |
| Upcroft, P | 1 |
| O'Donoghue, PJ | 1 |
| Upcroft, JA | 1 |
| Cudmore, SL | 1 |
| Delgaty, KL | 1 |
| Hayward-McClelland, SF | 1 |
| Petrin, DP | 1 |
| Garber, GE | 1 |
| French, L | 1 |
| Horton, J | 1 |
| Matousek, M | 1 |
| Piyadigamage, A | 1 |
| Wilson, J | 1 |
| Kazy, Z | 1 |
| Puhó, E | 1 |
| Czeizel, AE | 1 |
| Curioso, WH | 1 |
| Karras, BT | 1 |
| Campos, PE | 1 |
| Buendia, C | 1 |
| Holmes, KK | 1 |
| Kimball, AM | 1 |
| Price, MA | 1 |
| Stewart, SR | 1 |
| Behets, F | 1 |
| Dow, WH | 1 |
| Martinson, FE | 1 |
| Chilongozi, D | 1 |
| Cohen, MS | 1 |
| Durel, P | 1 |
| Couture, J | 1 |
| Bassoullet, MT | 1 |
| Høvik, P | 1 |
| Lossick, JG | 1 |
| Hartmann, AA | 1 |
| Elsner, P | 1 |
| Adler, MW | 1 |
| Felman, YM | 1 |
| Nikitas, JA | 1 |
| Trussell, RR | 1 |
| Beeley, L | 1 |
| Schlicht, JR | 1 |
| Hay, PE | 1 |
| Wawer, MJ | 2 |
| Gray, RH | 2 |
| Sewankambo, NK | 2 |
| Serwadda, D | 2 |
| Paxton, L | 1 |
| Berkley, S | 1 |
| McNairn, D | 1 |
| Wabwire-Mangen, F | 2 |
| Li, C | 1 |
| Nalugoda, F | 1 |
| Kiwanuka, N | 1 |
| Lutalo, T | 1 |
| Brookmeyer, R | 1 |
| Quinn, TC | 2 |
| Vahlensieck, W | 1 |
| Fieg, EL | 1 |
| Moodley, P | 1 |
| Sturm, AW | 1 |
| Eagan, L | 1 |
| Kigozi, G | 1 |
| Moulton, LH | 1 |
| O'Brien, KL | 1 |
| Meehan, M | 1 |
| Abramowsky, C | 1 |
| Robb, M | 1 |
| McCormack, WM | 1 |
| Stern, MS | 1 |
| MacKenzie, RG | 1 |
| Gray, JA | 1 |
| Kolibásová, K | 1 |
| Cervenková, D | 1 |
| Valentová, M | 1 |
| Koranyiová, K | 1 |
| Klobusický, M | 1 |
| Tyler, CW | 1 |
| Bergström, S | 1 |
| Martien, K | 1 |
| Emans, SJ | 1 |
| Simmons, PD | 1 |
| Blackwell, A | 1 |
| Watson, RA | 1 |
| Onifade, A | 1 |
| Osoba, AO | 1 |
| Rytter, M | 1 |
| Buchholz, W | 1 |
| Willocx, RR | 1 |
| Bell, DR | 1 |
| Lipenský, S | 1 |
20 reviews available for metronidazole and Sexually Transmitted Diseases
| Article | Year |
|---|---|
Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Male; | 2020 |
Pelvic inflammatory diseases: Updated French guidelines.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ceftriaxone; Doxycycline; Female; France; Gen | 2020 |
Chemotherapeutic options for the treatment of human trichomoniasis.
Topics: Antiprotozoal Agents; Drug Resistance; Female; Humans; Iridaceae; Lamiaceae; Metronidazole; Nifurate | 2019 |
Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Topics: Antitrichomonal Agents; Drug Resistance; Female; Humans; Male; Metronidazole; Recurrence; Sexually T | 2014 |
In vitro effects of various plants extracts on the growth of Trichomonas vaginalis.
Topics: Antitrichomonal Agents; Drug Resistance; Humans; Metronidazole; Plant Extracts; Sexually Transmitted | 2013 |
Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
Topics: Antiprotozoal Agents; Dysentery, Amebic; Entamoeba histolytica; Glyceraldehyde-3-Phosphate Dehydroge | 2009 |
Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.
Topics: Anti-Infective Agents; Coinfection; Directive Counseling; Female; HIV Infections; Humans; Metronidaz | 2013 |
Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Topics: Animals; Antitrichomonal Agents; Drug Resistance; Female; Humans; Metronidazole; Sexually Transmitte | 2003 |
Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Topics: Animals; Antitrichomonal Agents; Drug Resistance; Female; Humans; Metronidazole; Sexually Transmitte | 2004 |
Abnormal vaginal discharge: what does and does not work in treating underlying causes.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Clindamycin; Female; Humans; Me | 2004 |
Sexually transmitted vaginitis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Gardnerella vaginalis; Haemophilus Infections; | 1984 |
Prescribing in pregnancy. Infestations.
Topics: Animals; Anthelmintics; Antiprotozoal Agents; Bephenium Compounds; Cestode Infections; Female; Fetus | 1981 |
Treatment of bacterial vaginosis.
Topics: Adult; Clindamycin; Clinical Trials as Topic; Female; Gels; Humans; Metronidazole; Pregnancy; Pregna | 1994 |
[Sexually transmitted parasitoses and mycoses].
Topics: Adolescent; Adult; Antifungal Agents; Antitrichomonal Agents; Ectoparasitic Infestations; Female; Hu | 1999 |
Sexually transmitted infections, adverse pregnancy outcome and neonatal infection.
Topics: Diagnosis, Differential; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmi | 2000 |
Management of sexually transmissible infections during pregnancy.
Topics: Anti-Bacterial Agents; Candidiasis; Chlamydia Infections; Coitus; Condylomata Acuminata; Corynebacte | 1975 |
Antibacterial prophylaxis--a clinician's view.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Child; Child, Preschool; Female; Hum | 1979 |
The gynecologist's approach to sexually transmitted infections.
Topics: Ampicillin; Culture Techniques; Female; Gonorrhea; Humans; Metronidazole; Neisseria gonorrhoeae; Pen | 1975 |
Treatment of common genital infections in adolescents.
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Condylomata Acumina | 1987 |
Gardnerella vaginalis: genitourinary pathogen in men.
Topics: Adult; Bacteriuria; Balanitis; Child; Culture Media; Cystitis; Female; Gardnerella vaginalis; Genita | 1985 |
8 trials available for metronidazole and Sexually Transmitted Diseases
| Article | Year |
|---|---|
Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Topics: Centers for Disease Control and Prevention, U.S.; Female; HIV Infections; Humans; Infant, Newborn; M | 2022 |
Intravaginal metronidazole/miconazole for the treatment of vaginal trichomoniasis.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Alabama; Anti-Infective Agents; Dose-Resp | 2013 |
Prevention and control of sexually transmissible infections among hotel-based female sex workers in Dhaka, Bangladesh.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bangladesh; Candidiasis, Vulvovaginal; Cefixime; Ch | 2013 |
Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.
Topics: Adult; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination | 2016 |
Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Female; Humans; Levofloxacin; Metronidazole; Ofl | 2009 |
Nonspecific vaginitis in an outpatient clinic. Comparison of three dosage regimens of metronidazole.
Topics: Adolescent; Adult; Ambulatory Care; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fema | 1983 |
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; | 1998 |
Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda.
Topics: Azithromycin; Birth Weight; Cefixime; Drug Therapy, Combination; Endophthalmitis; Female; Folic Acid | 2001 |
43 other studies available for metronidazole and Sexually Transmitted Diseases
| Article | Year |
|---|---|
2-Methyl-4/5-nitroimidazole derivatives potentiated against sexually transmitted Trichomonas: Design, synthesis, biology and 3D-QSAR study.
Topics: Animals; Chemistry Techniques, Synthetic; Drug Design; Drug Resistance; HeLa Cells; Humans; Male; Me | 2016 |
Sexually Transmitted Infections: Updates From the 2021 CDC Guidelines.
Topics: Adolescent; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Chlamydia Infections; Dox | 2022 |
Vaginal discharge: evaluation and management in primary care.
Topics: Anti-Infective Agents; Antifungal Agents; Female; Fluconazole; Humans; Metronidazole; Primary Health | 2020 |
Evaluation of the effect of some medicinal plants on cultured Trichomonas Vaginalis.
Topics: Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Combinations; Female; Garlic; | 2020 |
Chlorinated metronidazole as a promising alternative for treating trichomoniasis.
Topics: Animals; Antiprotozoal Agents; Cell Line; Halogenation; Humans; Hydrogen Peroxide; Metronidazole; Ni | 2018 |
Phase solubility studies and anti-Trichomonas vaginalis activity evaluations of metronidazole and methylated β-cyclodextrin complexes: Comparison of CRYSMEB and RAMEB.
Topics: Antiprotozoal Agents; beta-Cyclodextrins; Calibration; Chromatography, High Pressure Liquid; Crystal | 2018 |
Survey of Obstetrician-gynecologists in the United States About Trichomoniasis, 2016.
Topics: Antiprotozoal Agents; Education, Medical, Continuing; Female; Gynecology; Health Knowledge, Attitude | 2019 |
Highly Potent 1
Topics: Anaerobiosis; Antiprotozoal Agents; Entamoeba histolytica; Foodborne Diseases; Giardia lamblia; Huma | 2018 |
Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?
Topics: Administration, Oral; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Metron | 2019 |
Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
Topics: Adolescent; Anti-Bacterial Agents; Arkansas; Ceftriaxone; Centers for Disease Control and Prevention | 2013 |
Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Male; Metronidazole; Middle Aged; Nucleic Acid Amplific | 2014 |
Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Candidiasis, Vulvovaginal; Clindamycin; Female | 2015 |
Fulminant amoebic enteritis that developed in the perinatal period.
Topics: Adult; Antiprotozoal Agents; Colon; Developed Countries; Dysentery, Amebic; Enteritis; Female; Human | 2015 |
Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Anti-Infective Agents; Female; Humans; Metronidazole; Mi | 2015 |
Should expedited partner treatment for women with Trichomonas vaginalis be recommended?
Topics: Antiprotozoal Agents; Female; Health Planning Guidelines; Humans; Male; Metronidazole; Randomized Co | 2010 |
Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis.
Topics: Adult; Animals; Antiprotozoal Agents; Cluster Analysis; Drug Resistance; Female; Genetic Variation; | 2012 |
Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Metronid | 2012 |
Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
Topics: Adolescent; Adult; Animals; Antitrichomonal Agents; Female; Humans; Metronidazole; Middle Aged; Poly | 2002 |
Metronidazole and pregnancy.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Bacterial Infections; F | 2002 |
CDC releases 2002 guidelines for treating STDs: Part I. Diseases characterized by vaginal discharge and PID.
Topics: Anti-Infective Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Metronidazole; Pelvic | 2002 |
Should we offer antibiotic prophylaxis post sexual assault?
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Chlamydia t | 2003 |
Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
Topics: Ambulatory Care; Ceftriaxone; Doxycycline; Drug Therapy, Combination; Female; Humans; Injections, In | 2005 |
Effect of vaginal metronidazole + miconazole treatment during pregnancy for gestational age and birth weight in a population-based study.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Birth Weight; Case-Control Studies; Female; | 2005 |
Design and implementation of Cell-PREVEN: a real-time surveillance system for adverse events using cell phones in Peru.
Topics: Anti-Infective Agents; Cell Phone; Computer Systems; Data Collection; Databases, Factual; Drug Monit | 2005 |
The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi.
Topics: Adult; Animals; Community Health Services; Cost-Benefit Analysis; Disease Transmission, Infectious; | 2006 |
The rapid detection of metronidazole in urine.
Topics: Aldehydes; Giardiasis; Humans; Indicators and Reagents; Metronidazole; Sexually Transmitted Diseases | 1967 |
[Gardnerella vaginalis infection--another sexually transmitted disease].
Topics: Bacteriological Techniques; Diagnosis, Differential; Female; Gardnerella vaginalis; Haemophilus Infe | 1984 |
ABC of sexually transmitted diseases. Vaginal discharge--management.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Leukorrhea; Male; Metronidazole; Pessa | 1983 |
1981 schedules for the treatment of the sexually transmitted diseases as recommended by the New York City Health Department Bureau of Venereal Disease Control Part II.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Administration Schedule; Erythromycin; Fem | 1981 |
Therapy of bacterial vaginosis.
Topics: Antitrichomonal Agents; Bacteroides; Bacteroides Infections; Clindamycin; Drug Therapy, Combination; | 1998 |
Prophylaxis for STDs after sexual assault.
Topics: Animals; Antitrichomonal Agents; Centers for Disease Control and Prevention, U.S.; Drug Therapy, Com | 1999 |
Drugs for sexually transmitted infections.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Azithromycin; Chlamydia | 1999 |
Data on HIV infection in women expands.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Drug Administration Schedule; Drug Therapy, Combinati | 1999 |
Venereal disease in adolescents.
Topics: Adolescent; Chlamydia Infections; Cytomegalovirus; Erythromycin; Female; Gonorrhea; Herpesviridae In | 1975 |
[Treatment of venereal inpatients for trichomoniasis with a single dose of metronidazole (author's transl)].
Topics: Adolescent; Adult; Female; Humans; Metronidazole; Middle Aged; Sexually Transmitted Diseases; Tricho | 1979 |
A prospective study on the perinatal outcome in Mozambican pregnant women with preterm rupture of membranes using two different methods of clinical management.
Topics: Adult; Amoxicillin; Chloroquine; Female; Fetal Membranes, Premature Rupture; Humans; Infant Mortalit | 1991 |
Sexually transmitted diseases in homosexual men.
Topics: Anti-Bacterial Agents; Homosexuality; Humans; Male; Metronidazole; Parasitic Diseases; Sexually Tran | 1985 |
Vaginal discharge.
Topics: Adult; Female; Humans; Leukorrhea; Metronidazole; Nystatin; Sexually Transmitted Diseases | 1985 |
Venereal disease among Nigerian women attending intra-uterine contraceptive device clinics.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Gonorrhea; Humans; | 1972 |
[Case report on the diagnosis of trichomonas ulcers].
Topics: Adult; Diagnosis, Differential; Female; Humans; Metronidazole; Penicillins; Pregnancy; Pregnancy Com | 1973 |
'Epidemiological' treatment in venereal diseases other than syphilis.
Topics: Epidemiologic Methods; Female; Gonorrhea; Humans; Imidazoles; Male; Methods; Metronidazole; Morpholi | 1973 |
Treatment of venereal diseases.
Topics: Chancroid; Drug Combinations; Erythromycin; Female; Gonorrhea; Granuloma Inguinale; Humans; Injectio | 1973 |
[Contribution to the occurrence and diagnostis of trichomoniasis in women].
Topics: Adolescent; Adult; Aged; Female; Germany, East; Humans; Male; Metronidazole; Middle Aged; Sexually T | 1965 |